SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-22-037204
Filing Date
2022-02-11
Accepted
2022-02-11 16:38:03
Documents
1
Group Members
NEW LEAF BIOPHARMA OPPORTUNITIES II, L.P. (BIOPHARMA II)NEW LEAF BPO ASSOCIATES II, L.P.NEW LEAF BPO MANAGEMENT II, L.L.C.NEW LEAF VENTURE ASSOCIATES III, L.P.NEW LEAF VENTURE MANAGEMENT III, L.L.C.RONALD M. HUNTVIJAY K. LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d149675dsc13ga.htm SC 13G/A 144930
  Complete submission text file 0001193125-22-037204.txt   147045
Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Ventures III, L.P. (Filed by) CIK: 0001625653 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Subject) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90647 | Film No.: 22621823
SIC: 2834 Pharmaceutical Preparations